BPIM
AQST icon

Brant Point Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Brant Point Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-35,512
Closed -$622K – 110
2018
Q3 		$622K Buy
+35,512
New +$585K 0.06% 129

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brant Point Investment Management's AQST Position: Q4 2018 in Review

Brant Point Investment Management sold out of Aquestive Therapeutics (AQST) in Q4 2018, closing a stake of 35,512 shares — an estimated $622K sold.

Brant Point Investment Management first reported a position in AQST in Q3 2018 and held it in 1 quarter. The position peaked at $622K in Q3 2018. 36 funds tracked by Wall St. Rank hold AQST as of Q4 2018.

  • Brant Point Investment Management reported no remaining Aquestive Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Brant Point Investment Management sold 35,512 Aquestive Therapeutics shares in Q4 2018, an estimated $622K.
  • Brant Point Investment Management first reported a position in Aquestive Therapeutics in Q3 2018 and held it in 1 quarter.
  • Brant Point Investment Management's Aquestive Therapeutics position peaked at $622K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2018.

Based on Brant Point Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.